OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model
Rofida A. Saleh, Tarek F. Eissa, Dalaal M. Abdallah, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
Yixuan Wang, Hao Hu, Xinyu Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 35

Protective effect of a hydromethanolic extract from Fraxinus excelsior L. bark against a rat model of aluminum chloride-induced Alzheimer's disease: Relevance to its anti-inflammatory and antioxidant effects
Amin Iranpanah, Sajad Fakhri, Gholamreza Bahrami, et al.
Journal of Ethnopharmacology (2024) Vol. 323, pp. 117708-117708
Closed Access | Times Cited: 10

Harmine prevents 3-nitropropionic acid-induced neurotoxicity in rats via enhancing NRF2-mediated signaling: Involvement of p21 and AMPK
Mohamed Z. Habib, Mariane G. Tadros, Hadwa A. Abd-Alkhalek, et al.
European Journal of Pharmacology (2022) Vol. 927, pp. 175046-175046
Closed Access | Times Cited: 26

Inhibiting NLRP3 Inflammasome Activation by CY-09 Helps to Restore Cerebral Glucose Metabolism in 3×Tg-AD Mice
Shuangxue Han, Zhijun He, Xia Hu, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 722-722
Open Access | Times Cited: 15

WIN55,212-2 Attenuates Cognitive Impairments in AlCl3 + d-Galactose-Induced Alzheimer’s Disease Rats by Enhancing Neurogenesis and Reversing Oxidative Stress
Onesimus Mahdi, Samaila Musa Chiroma, Mohamad Taufik Hidayat Baharuldin, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1270-1270
Open Access | Times Cited: 27

Therapeutics to Treat Psychiatric and Neurological Disorders: A Promising Perspective from Algerian Traditional Medicine
Farida Larit, Francisco León
Plants (2023) Vol. 12, Iss. 22, pp. 3860-3860
Open Access | Times Cited: 12

High Glucose Concentration on the Metabolic Activity of C6 Glia Cells: Implication in Alzheimer’s Disease
Karla Aketzalli Hernández-Contreras, Fausto Rojas-Durán, Marı́a Elena Hernández, et al.
BioMed (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access

Ethnobotanical Survey and Pharmacological Screening of Medicinal Plants Used as Antihypertensive in Sefrou Province (Middle-North of Morocco): Benefits and Challenges
Badiaâ Lyoussi, Meryem Bakour, Khadija Cherkaoui-Tangi, et al.
Frontiers in Bioscience-Scholar (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8

Roles of traditional chinese medicine regulating neuroendocrinology on AD treatment
Chujun Deng, Huize Chen, Zeyu Meng, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 13

GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for CombatingAlzheimer’s Disease through its Supporting DPP4 Inhibitors: A Review
Mohammad Abubakar, Lokesh Nama, Mohammad Arif Ansari, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1635-1664
Closed Access | Times Cited: 2

The Neuroprotective and Therapeutic Effects of Medicinal Plants and Natural Products against Aluminium Chloride-Induced Alzheimer’s Disease: Recent Update
Ayodeji Oluwatobi Ojetunde
Biology Medicine & Natural Product Chemistry (2024) Vol. 13, Iss. 1, pp. 7-33
Open Access | Times Cited: 2

MicroRNA‐140‐5p inhibitor attenuates memory impairment induced by amyloid‐ß oligomer in vivo possibly through Pin1 regulation
Pariya Khodabakhsh, Maryam Bazrgar, Fatemeh Mohagheghi, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 29, Iss. 1, pp. 91-103
Open Access | Times Cited: 10

Chemical components and against alzheimer's disease effects of the calyxes of Physalis alkekengi L. var. franchetii (Mast.) Makino
Yang Teng, Gao Jia, Tian Tan, et al.
Journal of Chemical Neuroanatomy (2024) Vol. 136, pp. 102390-102390
Closed Access | Times Cited: 1

Phytochemical, Pharmacological, and Toxicological Studies on Peganum harmala L.: An Overview of the Last Decade
İçim Gökkaya, Gülin Renda, Tuğba Subaş, et al.
Clinical and Experimental Health Sciences (2023) Vol. 13, Iss. 3, pp. 664-678
Open Access | Times Cited: 2

Type 2 diabetes mellitus: Novel targets and multitarget-directed phytotherapy
Abu Sufiyan Chhipa, Srashti Verma, Snehal S. Patel
Elsevier eBooks (2024), pp. 385-408
Closed Access

Virtual Screening of Nrf2 Dietary-Derived Agonists and Safety by a New Deep-Learning Model and Verified In Vitro and In Vivo
Song Liu, Huan-Huan Qin, Xinran Ji, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 21, pp. 8038-8049
Closed Access | Times Cited: 1

Therapeutic Effects Of Combined and Chronic Treatment of Tat-GluA23y and D-Serine on Cognitive Dysfunction in Postmenopausal Rats
Parvin Babaei, Shirin Javer, Mahmood Abedinzade
Experimental Aging Research (2023) Vol. 50, Iss. 5, pp. 633-651
Closed Access | Times Cited: 1

Chemical constituents from the aerial part of Peganum multisectum
Bingxue Zhou, Kun Duan, Li Kong, et al.
Biochemical Systematics and Ecology (2021) Vol. 98, pp. 104326-104326
Closed Access

Page 1

Scroll to top